NCT00656240已完成2 期
A Randomized, Double-Masked, Parallel-Group Trial of DE-104 Ophthalmic Solution in Subjects With Open-Angle Glaucoma or Ocular Hypertension
适应症
干预措施
相关药物
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 试验地点
- 1
研究概览
简要总结
To investigate the intraocular pressure (IOP)-lowering effect and safety of DE-104 ophthalmic solution in patients with Primary Open-Angle Glaucoma or Ocular Hypertension
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 20 Years 至 74 Years（Adult, Older Adult）
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Diagnosed with primary open-angle glaucoma or ocular hypertension.
- •Provided signed, written informed consent.
- •If a subject is a female of childbearing potential, she must utilize reliable contraceptive throughout the study, and must have a negative urine pregnancy test prior to enrollment into this study.
排除标准
- •Females who are pregnant, nursing or planning a pregnancy, or females of childbearing potential who are not using a reliable method of contraception.
- •Presence of any abnormality or significant illness that could be expected to interfere with the study.
研究组 & 干预措施
1
Experimental
干预措施: DE-104 ophthalmic solution (Drug)
2
Experimental
干预措施: DE-104 vehicle (Drug)
研究者
研究点 (1)
Loading locations...
相似试验
已完成
2 期
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-Angle Glaucoma or Ocular HypertensionOcular HypertensionOpen-Angle GlaucomaNCT00657579Santen Pharmaceutical Co., Ltd.
已完成
2 期
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular HypertensionNCT00650338Santen Inc.165
已完成
1 期
Safety and Efficacy Study of DE-104 Ophthalmic Solution to Treat Open-angle Glaucoma or Ocular HypertensionOpen-Angle GlaucomaOcular HypertensionNCT00868894Santen Inc.49
已完成
3 期
Study of DE-108 Ophthalmic Solution in Patients Who Are Scheduled for Cataract SurgeryCataract SurgeryNCT02573610Santen Pharmaceutical Co., Ltd.576
已完成
4 期
Travoprost 0.004% Versus Pilocarpine 1% in Patients With Chronic Angle Closure Glaucoma (CACG)Angle-closure GlaucomaNCT00762645Alcon Research30